What it sells
Semi-Autonomous Diagnostics for Emergent Care
Business model breakdown
Buyer: who owns the budget?
UnverifiedHospital emergency medicine/radiology leadership with CIO/IT security sign-off (site stresses security review and clinical leadership control).
Trigger: what makes them buy now?
UnverifiedTime-sensitive emergencies such as intracranial hemorrhage where delayed imaging reads and handoffs slow treatment, transfer or discharge.
Workflow: what inputs become what output?
Imaging and clinical data flow from PACS/RIS/EHR via DICOM/HL7/FHIR into Caire, models produce structured findings (detection, severity, location, quantification), site-defined rules route alerts and escalate unanswered events to ED, radiology, specialty and transfer teams, and pathway intervals are measured.
Economics: what it saves and how it charges
UnverifiedLikely enterprise software licence per hospital/site; site cites 98.05% ICH detection accuracy in a 510-scan external validation study but gives no price.
Distribution: how it reaches customers
Enterprise hospital sales: "Talk to our team", "Request a clinical briefing" and "Request an architecture session"; no self-serve signup.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Summer 2021 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.